Literature DB >> 200359

Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.

L H Baker, J H Saiki, S E Jones, J S Hewlett, R W Brownlee, R L Stephens, V K Vaitkevicius.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200359

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  6 in total

Review 1.  Update in cancer chemotherapy: gastrointestinal cancer, cancer of the small intestines, gallbladder, liver, and esophagus.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-08       Impact factor: 1.798

2.  Intra-arterial administration of epirubicin in the treatment of nonresectable hepatocellular carcinoma. Epirubicin Study Group for Hepatocellular Carcinoma.

Authors: 
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Right trisegmentectomy for hepatic neoplasms.

Authors:  T E Starzl; L J Koep; R Weil; J R Lilly; C W Putnam; J A Aldrete
Journal:  Surg Gynecol Obstet       Date:  1980-02

4.  [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)].

Authors:  G Ehninger; H J Stocker; B Proksch; K Wilms
Journal:  Klin Wochenschr       Date:  1980-09-15

5.  [Approaches to a selective chemotherapy of hepatocellular carcinoma (author's transl)].

Authors:  J Pausch; A Holstege; D Keppler; W Gerok
Journal:  Klin Wochenschr       Date:  1981-06-15

6.  Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma.

Authors:  S K Ji; N H Park; H M Choi; Y W Kim; S H Lee; K H Lee; S Y Ahn; S U Lee; B H Han; B C Park
Journal:  Korean J Intern Med       Date:  1996-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.